The Vanguard Group 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Axsome Therapeutics, Inc. AXSM | The Vanguard Group | 3,696,766 7.810% | 279,138 (+8.17%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Axsome Therapeutics, Inc. AXSM | The Vanguard Group | 3,417,628 7.870% | 732,006 (+27.26%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | The Vanguard Group | 2,685,622 7.130% | 44,548 (+1.69%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | The Vanguard Group | 2,641,074 7.070% | 2,641,074 (New Position) | Filing |